


Ask a doctor about a prescription for DUSPATALIN 135 mg FILM-COATED TABLETS
Duspatalin 135 mg coated tablets
Mebeverine hydrochloride
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
Duspatalin contains mebeverine hydrochloride as the active ingredient, which belongs to the group of medications called antispasmodics, which act on the intestine.
What is Duspatalin used for
Duspatalin is used to relieve symptoms of irritable bowel syndrome (IBS) and other similar diseases, such as irritable colon in adults.
Irritable bowel syndrome is a very common disease that causes spasms and pain in the intestine.
The intestine is a long muscular tube through which food passes to be digested. If a spasm occurs in the intestine and the pressure is too strong, it causes pain.
Symptoms vary from person to person but may include:
Your diet and lifestyle can also help treat irritable bowel syndrome (IBS)
A high-fiber diet may be helpful, but consult your doctor or pharmacist beforehand for more information. Relaxation can help reduce IBS symptoms.
Do not take Duspatalin- If you are allergic to mebeverine hydrochloride or any of the other components of this medication (listed in section 6).
If you have intestinal obstruction (paralytic ileus).
Warnings and precautions
Consult your doctor or pharmacist before starting to take Duspatalin.
If you develop new symptoms or if your symptoms have worsened.
Other medications and Duspatalin
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Duspatalin is not recommended during pregnancy or breastfeeding.
Driving and using machines
It is unlikely that this medication will affect your ability to drive or operate tools or machines.
Duspatalin contains lactose and sucrose
This medication contains lactose and sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the exact administration instructions for this medication as indicated by your doctor. Consult your doctor or pharmacist if you have doubts.
Taking this medication
Use in adults
Use in children and adolescents
This medication is not recommended for use in children and adolescents under 18 years of age due to insufficient data.
If you take more Duspatalin than you should:
If you have taken more Duspatalin than you should, consult your doctor, pharmacist, or the Toxicology Information Service, phone 91 562 04 20, or go immediately to a hospital.
Bring the packaging and this leaflet with you.
If you forget to take Duspatalin:
Do not take a double dose to make up for forgotten doses.
If you stop treatment with Duspatalin
Do not stop treatment with Duspatalin without consulting your doctor first.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Stop taking Duspatalin and see a doctor immediately if you experience any of the following serious side effects, as you may need urgent medical treatment:
Other side effects are:
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging, after CAD or EXP. The expiration date is the last day of the month indicated.
Store below 25°C.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and unused medications at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. This will help protect the environment.
Composition of Duspatalin
The active ingredient is mebeverine hydrochloride. Each tablet contains 135 mg of mebeverine hydrochloride.
The other ingredients (excipients) are: lactose monohydrate, sodium carboxymethyl starch (type A) (derived from potato starch), povidone, talc, magnesium stearate, sucrose, gum arabic, gelatin, and carnauba wax.
Appearance of the product and package contents
White, round, coated tablets.
Duspatalin is available in boxes of 60 coated tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
RECIPHARM PARETS, S.L.
Ramon y Cajal, 2
08150 Parets del Valles, Spain
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 - Madrid
Spain
Date of the last revision of this leaflet: February 2020.
Detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/
The average price of DUSPATALIN 135 mg FILM-COATED TABLETS in November, 2025 is around 5.2 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DUSPATALIN 135 mg FILM-COATED TABLETS – subject to medical assessment and local rules.